Potential Klebsiella Bacteriocin with Efficacy Toward the Enterobacteriaceae Family

Faculty Mentor

Dr. Sean Fox

Mentor Home Department

Health Sciences

Short Abstract

Drug resistance is a prevalent issue in patient treatment. The CDC estimates 23,000 people die yearly in the United States from antibiotic-resistant infections. Microbes produce a range of antimicrobials: antibiotics, metabolites, and lytic agents. Bacteriocins differ from antibiotics as they have a narrow killing spectrum and toxicity to bacteria. We characterized a Klebsiella bacteriocin by isolating a plasmid from Klebsiella that encodes a novel bacteriocin with efficacy towards Enterobacteriaceae family members and offers alternative treatment for drug resistant.

Category

Science and Technology

Start Date

24-4-2023 9:00 AM

End Date

24-4-2023 9:15 AM

Location

D.P. Culp Center Room 271J

This document is currently not available here.

Share

COinS
 
Apr 24th, 9:00 AM Apr 24th, 9:15 AM

Potential Klebsiella Bacteriocin with Efficacy Toward the Enterobacteriaceae Family

D.P. Culp Center Room 271J

Drug resistance is a prevalent issue in patient treatment. The CDC estimates 23,000 people die yearly in the United States from antibiotic-resistant infections. Microbes produce a range of antimicrobials: antibiotics, metabolites, and lytic agents. Bacteriocins differ from antibiotics as they have a narrow killing spectrum and toxicity to bacteria. We characterized a Klebsiella bacteriocin by isolating a plasmid from Klebsiella that encodes a novel bacteriocin with efficacy towards Enterobacteriaceae family members and offers alternative treatment for drug resistant.